A sustained-release intracanalicular dexamethasone insert (Dextenza) for pediatric cataract surgery

We assess the outcomes of a sustained-release intracanalicular dexamethasone insert (Dextenza) in the treatment of postoperative ocular inflammation in children undergoing cataract surgery. Seventeen eyes of 17 children were analyzed. The anterior chamber was clear in 18% of eyes at 1-2 weeks after surgery. A spike in intraocular pressure requiring intervention was observed in 18% of eyes. Rescue medications using topical steroids were required in 29% of eyes. Our initial experience suggests that the dexamethasone insert reduced or eliminated the need for postoperative steroid drops.

Automated summary

The use of intracanalicular dexamethasone insert can reduce or eliminate the need for postoperative steroid drops in children undergoing cataract surgery, although some eyes still require rescue treatment with topical steroids.